Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provide written informed consent approved by the appropriate ethics committee
Age 18 years or older
Understand study procedures and have the ability and willingness to abide by all procedures during the study
Capable of providing informed consent
Diagnosis of glaucoma
You may not be if
Pregnant or breastfeeding
Presence of any ocular pathology other than glaucoma that contributes to severe vision loss (retinopathy, maculopathy, severe uveitis, keratopathy, etc.)
Diagnosis of glucose intolerance, type 1 or type 2 diabetes mellitus
Inability to perform reliable visual field testing
Unable to provide informed consent
Unable to complete the tests and follow-ups required by the study
Clareo Health | Topical Insulin for Glaucoma (TING2)
